MyFinsight
Home
Compare
About
Recent SEC Filings
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
Rein Therapeutics, Inc. (RNTX)
Rein Therapeutics, Inc. (RNTX)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
|
Compare
Cash Flow Overview
Change in Cash
$4,097K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Proceeds from issuance of common...
Net amortization of discount on ...
Non-cash warrant issuance cost
Others
Negative Cash Flow Breakdown
Purchases of short-term investme...
Repayment of notes payable
Purchases of long-term investmen...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Research and development expenses
3,638
3,073
-
-
General and administrative expenses
2,438
2,157
-
-
Other income
178
-
-
-
Other (expense) income, net
-
-608
-
-
Other expense
1,085
-
-
-
Net loss
-6,375
-5,838
-31,967
-5,581
Commitment fee related to pre-paid advance agreement
-
-
0
300
Original issue discount related to pre-paid advance agreement
-
-
50
100
Depreciation and amortization expense
0
-
0
0
Net amortization of discount on notes payable
452
623
-
-
Non-cash warrant issuance cost
423
-
-
-
Changes in fair value of warrant liabilities
8
-
-
-
Accretion of discount on investments
12
-
-
-
Stock-based compensation expense
164
156
257
1,447
Impairment loss on intangible assets
-
-
28,700
-
Prepaid expenses and other current assets
-202
-103
-15
219
Other assets
705
1,003
0
-2,344
Accounts payable
-1,888
2,288
-147
-1,905
Operating lease liabilities
-
-
0
0
Accrued expenses and other current liabilities
-909
247
584
-34
Other long-term liabilities
0
0
0
0
Deferred tax liabilities
-
-
-712
-
Net cash used in operating activities
-8,640
-3,424
-3,220
-3,548
Purchases of short-term investments
32,094
-
-
-
Purchases of long-term investments
2,979
-
-
-
Net cash used in investing activities
-35,073
-
-
-
Proceeds from issuance of common stock, net of offering costs
53,190
354
1,452
0
Proceeds from notes payable
0
4,300
-
-
Proceeds from pre-paid advances
-
-
-
1,900
Proceeds from pre-paid advances, net of discounts
-
-
2,850
-
Repayment of notes payable
5,375
-
-
-
Proceeds from issuance of common stock in connection with stock option exercises
0
0
3
0
Proceeds from issuance of common stock in connection with warrant exercises
0
-
0
0
Proceeds from issuance of warrants, net of offering costs
0
-
0
0
Proceeds from warrant exchanges, net of offering costs
0
-
0
0
Proceeds from warrant exercises with common stock subscribed
0
-
0
0
Net cash provided by financing activities
47,815
4,654
2,405
1,900
Effect of exchange rate changes on cash and cash equivalents
-5
-
-18
-26
Net increase (decrease) in cash and cash equivalents
4,097
1,230
-833
-1,674
Cash and cash equivalents at beginning of period
4,445
3,215
4,048
12,865
Cash and cash equivalents at end of period
8,542
4,445
3,215
4,048
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
RNTX Cash Flow Sankey Diagram
Sankey diagram visualizing RNTX cash flow for the period
Proceeds from issuance of
common stock, net of...
$53,190K
(14393.19%↑ Y/Y)
Net cash provided by
financing activities
$47,815K
(777.34%↑ Y/Y)
Canceled cashflow
$5,375K
Net increase
(decrease) in cash and cash...
$4,097K
(157.36%↑ Y/Y)
Canceled cashflow
$43,718K
Repayment of notes payable
$5,375K
Net amortization of
discount on notes payable
$452K
Non-cash warrant
issuance cost
$423K
Prepaid expenses and
other current assets
-$202K
(-275.65%↓ Y/Y)
Stock-based compensation
expense
$164K
(-68.46%↓ Y/Y)
Changes in fair value of
warrant liabilities
$8K
Net cash used in
investing activities
-$35,073K
Net cash used in
operating activities
-$8,640K
(31.39%↑ Y/Y)
Effect of exchange rate
changes on cash and cash...
-$5K
Canceled cashflow
$1,249K
something is missing
$608K
Other income
$178K
Purchases of short-term
investments
$32,094K
Purchases of long-term
investments
$2,979K
Net loss
-$6,375K
(48.27%↑ Y/Y)
Accounts payable
-$1,888K
(-136.90%↓ Y/Y)
Accrued expenses and
other current...
-$909K
(71.34%↑ Y/Y)
Canceled cashflow
$786K
Other assets
$705K
(-69.92%↓ Y/Y)
Accretion of discount on
investments
$12K
Research and development
expenses
$3,638K
General and
administrative expenses
$2,438K
Other expense
$1,085K
Buy us a coffee